Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Frampton

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Cancer Research|September 1, 1983
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolitesR J Frampton, S A Omond, J A Eisman
The Journal of Endocrinology|July 1, 1991
Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R G Larkins
Cell|April 5, 1996
MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiationM H Sieweke, H Tekotte, J Frampton, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1989
Ovarian fibromatosis with minor sex cord elements. Case reportP Byrne, E J Vella, T Rollason, et al.
Gene|December 1, 1982
Sensitive detection of RNA using strand-specific M13 probesD M Brown, J Frampton, P Goelet, et al.
Annals of the Royal College of Surgeons of England|November 8, 2012
How safe is diathermy in patients with cochlear implants?S J Frampton, H Ismail-Koch, T E Mitchell
Cell Biochemistry and Function|April 1, 1986
Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell linesJ A Eisman, R J Frampton, F J McLean
Biology of the Neonate|January 1, 1986
Changes in plasma amino acids in the developing chickR J Frampton, R W Yardley, R A MacMahon
The Australian and New Zealand Journal of Surgery|February 1, 1984
1,25-dihydroxyvitamin D3 and breast cancerJ A Eisman, L J Suva, R J Frampton
Leukemia|April 1, 1997
MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1M H Sieweke, H Tekotte, J Frampton, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research|September 1, 1983
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolitesR J Frampton, S A Omond, J A Eisman
The Journal of Endocrinology|July 1, 1991
Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R G Larkins
Cell|April 5, 1996
MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiationM H Sieweke, H Tekotte, J Frampton, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1989
Ovarian fibromatosis with minor sex cord elements. Case reportP Byrne, E J Vella, T Rollason, et al.
Gene|December 1, 1982
Sensitive detection of RNA using strand-specific M13 probesD M Brown, J Frampton, P Goelet, et al.
Annals of the Royal College of Surgeons of England|November 8, 2012
How safe is diathermy in patients with cochlear implants?S J Frampton, H Ismail-Koch, T E Mitchell
Cell Biochemistry and Function|April 1, 1986
Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell linesJ A Eisman, R J Frampton, F J McLean
Biology of the Neonate|January 1, 1986
Changes in plasma amino acids in the developing chickR J Frampton, R W Yardley, R A MacMahon
The Australian and New Zealand Journal of Surgery|February 1, 1984
1,25-dihydroxyvitamin D3 and breast cancerJ A Eisman, L J Suva, R J Frampton
Leukemia|April 1, 1997
MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1M H Sieweke, H Tekotte, J Frampton, et al.
Pageof 11